Clinical Trials Directory

Trials / Completed

CompletedNCT03484104

Cerebral Perfusion in Hypothermic Circulatory Arrest

Cerebral Perfusion During Cardiac Surgery With Hypothermic Circulatory Arrest

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Selective antegrade cerebral perfusion (sACP) during aortic arch surgery in hypothermic circulatory arrest (HCA) is an established method for intraoperative neuroprotection. Although sACP is established as a beneficial method to reduce secondary neurological side effects due to brain-malperfusion, there are several parameters like sACP flow rate, perfusion pressure or temperature of the perfusate, where the optimal values remain unclear. The flow rate of the sACP-perfusate is increased according to center-specific standard-procedures. The optimal sACP flow rate, monitored by near infrared spectroscopy (NIRS), is to be investigated in this single center clinical prospective observational study. 40 Patients are enrolled over an estimated period of 14 months.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMeasurement of tissue oxygenation index (TOI)TOI and Vmca measurement during cardiac surgery with hypothermic circulatory arrest

Timeline

Start date
2018-07-01
Primary completion
2021-09-28
Completion
2021-09-28
First posted
2018-03-30
Last updated
2021-09-29

Locations

2 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03484104. Inclusion in this directory is not an endorsement.